World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
38497
World Ranking
4805
National Ranking
2609

Philip B. Paty publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philip B. Paty sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 398 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philip B. Paty D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philip B. Paty sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 114 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Philip B. Paty is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on Medicine, with an emphasis on Oncology, Surgery, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, and Cancer Research.

The main topics of their work include colorectal cancer surgical treatments, colorectal and anal carcinomas, genetic factors in colorectal cancer, colorectal cancer treatments and studies, colorectal cancer screening and detection, gastric cancer management and outcomes, and radiomics and machine learning in medical imaging.

Philip B. Paty has contributed to numerous publications in various journals. Frequent publication venues for their research include:

  • Journal of Clinical Oncology
  • Annals of Surgical Oncology
  • Diseases of the Colon & Rectum
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research

Their recent papers cover several significant topics in colorectal cancer treatment and research:

  • Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy, 2022, Journal of Clinical Oncology
  • Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy, 2020, Clinical Cancer Research
  • Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial, 2023, Journal of Clinical Oncology
  • Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer, 2022, Nature Medicine
  • Patient-Reported Bowel Function in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy After Neoadjuvant Therapy: A Case-Control Study, 2020, Diseases of the Colon & Rectum

Frequent collaborators in their research include Julio García-Aguilar, Martin R. Weiser, J. Joshua Smith, Garrett M. Nash, and Emmanouil P. Pappou. Paty's collaboration network shows a concentrated involvement with researchers specialized in colorectal cancer and surgical oncology.

Best Publications

  • Wound Tissue Oxygen Tension Predicts the Risk of Wound Infection in Surgical Patients

    Harriet Williams Hopf;Thomas K. Hunt;Judith M. West;Peter Blomquist

  • Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

    Robert Martin;Philip Paty;Yuman Fong;Andrew Grace

  • Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

    Andrea Cercek;Campbell S.D. Roxburgh;Campbell S.D. Roxburgh;Paul Strombom;J. Joshua Smith

  • Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets

    Seung Myung Dong;Giovanni Traverso;Constance M Johnson;Li Geng

  • Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

    Jose G. Guillem;David B. Chessin;Alfred M. Cohen;Jinru Shia

  • Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial

    Deborah Schrag;Martin R. Weiser;Karyn A. Goodman;Mithat Gon̈en

  • Long-Term Results of Local Excision for Rectal Cancer

    Philip B. Paty;Garrett M. Nash;Paul Baron;Maureen Zakowski

  • Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

    J. Joshua Smith;Paul Strombom;Oliver S. Chow;Campbell S. Roxburgh;Campbell S. Roxburgh

  • Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy.

    James D. Smith;Jeannine A. Ruby;Karyn A. Goodman;Leonard B. Saltz

  • Neuroendocrine carcinomas of the colon and rectum.

    P. E. Bernick;D. S. Klimstra;J. Shia;B. Minsky

  • Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

    Selvaraju Veeriah;Barry S Taylor;Shasha Meng;Fang Fang

  • Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer

    Michal Sheffer;Manny D. Bacolod;Or Zuk;Sarah F. Giardina

  • Extracellular metabolic energetics can promote cancer progression.

    Jia Min Loo;Alexis Scherl;Alexander Nguyen;Fung Ying Man

  • A rectal cancer organoid platform to study individual responses to chemoradiation.

    Karuna Ganesh;Chao Wu;Kevin P. O’Rourke;Bryan C. Szeglin

  • Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.

    Warren E. Enker;Nipun Merchant;Alfred M. Cohen;Nicole M. Lanouette

  • Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

    J. Joshua Smith;Oliver S. Chow;Marc J. Gollub;Garrett M. Nash

  • Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients.

    Leyo Ruo;Christina Gougoutas;Philip B Paty;Jose G Guillem

  • Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma

    Nancy E. Kemeny;Fidel D. Huitzil Melendez;Marinela Capanu;Philip B. Paty

  • Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line

    Mariangela Mancini;Benjamin O. Anderson;Elizabeth Caldwell;Monireh Sedghinasab

  • Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy

    Leyo Ruo;Satish Tickoo;David S. Klimstra;Bruce D. Minsky

Frequent Co-Authors

Jose G. Guillem
Jose G. Guillem University of North Carolina at Chapel Hill
Martin R. Weiser
Martin R. Weiser Memorial Sloan Kettering Cancer Center
Jinru Shia
Jinru Shia Memorial Sloan Kettering Cancer Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
W. Douglas Wong
W. Douglas Wong Memorial Sloan Kettering Cancer Center
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
Julio Garcia-Aguilar
Julio Garcia-Aguilar Memorial Sloan Kettering Cancer Center
Alfred M. Cohen
Alfred M. Cohen Cancer Prevention Pharmaceuticals (United States)
J. Joshua Smith
J. Joshua Smith Memorial Sloan Kettering Cancer Center
Nancy E. Kemeny
Nancy E. Kemeny Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying medicine in the USA, it’s worth exploring related online degrees and career pathways. The healthcare field offers diverse options beyond becoming a physician, each with unique advantages and educational requirements.

For those interested in leadership roles, pursuing a Master of Healthcare Administration (MHA) is a popular option. Many students look for the cheapest mha programs online to balance affordability and quality. Comparing costs is essential, so understanding the cost of mha degree programs can help you make an informed decision.

Advanced practice nurses may benefit from the cheapest online dnp programs, allowing them to combine clinical expertise with leadership skills.

Pharmacists seeking career advancement also have options for distance learning. Earning an online pharmacist degree can create pathways in research, clinical practice, and administration.

Exploring these online degrees can open doors to specialized roles in healthcare, often with greater flexibility and accessibility than traditional routes.

Best Scientists Citing Philip B. Paty

Trending Scientists

Recently Published Articles